Editorial: Entering the RNA Wonderland: Opportunities and Challenges for RNA Therapeutics in the Cardiovascular System

• Anna Zampetaki,
• Lars Maegdefessel,
• Lars Maegdefessel,
• Lars Maegdefessel

Affiliations

Anna Zampetaki

King's British Heart Foundation Centre, King's College London, London, United Kingdom

Lars Maegdefessel

Department of Vascular and Endovascular Surgery, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany

Lars Maegdefessel

German Center for Cardiovascular Research (DZHK), Munich, Germany

Lars Maegdefessel

Department of Medicine, Karolinska Institutet, Stockholm, Sweden